SCHEMBL1705596

SCHEMBL1705596

N#CC(=Cc1ccc(O)cc1)C(N)=C(C#N)C#N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 1.00
EGFR P00533 7/20 1.00
MEN1 O00255 6/20 1.00
KMT2A Q03164 6/20 1.00
HPGD P15428 5/20 1.00
CYP3A4 P08684 3/20 1.00
CYP1A2 P05177 3/20 1.00
BLM P54132 3/20 1.00
HSD17B10 Q99714 3/20 1.00
PKM P14618 2/20 1.00
TSHR P16473 2/20 1.00
MAPK1 P28482 2/20 1.00
PMP22 Q01453 2/20 1.00
HIF1A Q16665 2/20 1.00
KDM4E B2RXH2 4/20 0.59
CISD1 Q9NZ45 2/20 0.59
SLC16A3 O15427 1/20 0.59
SLC16A1 P53985 1/20 0.59
GPR35 Q9HC97 1/20 0.59
MAPT P10636 5/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10144540 1.00 ALDH1A1 (1.00) ALDH1A1EGFRMEN1KMT2AHPGD
SCHEMBL17610618 1.00 ALDH1A1 (1.00) ALDH1A1EGFRMEN1KMT2AHPGD
SCHEMBL25736023 0.90 ALDH1A1 (0.82) ALDH1A1EGFRMEN1KMT2AHPGD
SCHEMBL10144267 0.83 ALDH1A1 (0.71) ALDH1A1EGFRMEN1KMT2AHPGD
SCHEMBL13060204 0.82 ALDH1A1 (0.74) ALDH1A1EGFRMEN1KMT2AHPGD
SCHEMBL25737631 0.81 EGFR (1.00) ALDH1A1EGFRMEN1KMT2AHPGD
SCHEMBL28509763 0.80 KMT2A (0.67) ALDH1A1EGFRMEN1KMT2AHPGD
SCHEMBL9539321 0.80 KDM4E (0.71) ALDH1A1EGFRMEN1KMT2AHPGD
SCHEMBL9539318 0.80 KDM4E (0.71) ALDH1A1EGFRMEN1KMT2AHPGD
Tyrphostin 51 SCHEMBL241622 0.77 EGFR (0.80) ALDH1A1EGFRMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1156775-B1 REDUCTION OF HAIR GROWTH GILLETTE CO (US) 2006-05-17 EP claimed
US-6121269-A TOPICALLY APPLYING A PROTEIN-TYROSINE KINASE INHIBITOR TO SKIN TO REDUCE ANDROGEN-STIMULATED HAIR GROWTH WITHOUT SIDE EFFECTS GILLETTE COMPANY, THE, A DELAWARE CORPORATION 2000-09-19 US claimed
US-11406709-B2 Therapeutic and research application of PDCL3 TRUSTEES OF BOSTON UNIVERSITY (US) 2022-08-09 US disclosed
US-20170274075-A1 THERAPEUTIC AND RESEARCH APPLICATION OF PDCL3 TRUSTEES OF BOSTON UNIVERSITY (US) 2017-09-28 US disclosed
WO-2016044219-A1 THERAPEUTIC AND RESEARCH APPLICATION OF PDCL3 TRUSTEES OF BOSTON UNIVERSITY (US) 2016-03-24 WO disclosed
EP-2097059-B1 CLEANSING OR CARE PRODUCT HENKEL KGAA (DE) 2012-04-18 EP disclosed
EP-2167017-A2 COSMETIC STICK BASED ON A CONGEALED OIL-IN-WATER DISPERSION/EMULSION HAVING A HYDROGEL FORMER Henkel AG & Co. KGaA (DE) 2010-03-31 EP disclosed
EP-2167018-A2 COSMETIC STICK BASED ON A CONGEALED OIL-IN-WATER DISPERSION/EMULSION Henkel AG & Co. KGaA (DE) 2010-03-31 EP disclosed
US-20100047296-A1 Low-Residue Cosmetic Or Dermatological Stick Based On An Oil-In-Water Dispersion/Emulsion III HENKEL AG & CO. KGAA (DE) 2010-02-25 US disclosed
EP-2097059-A1 CLEANSING OR CARE PRODUCT Henkel Kommanditgesellschaft auf Aktien (DE) 2009-09-09 EP disclosed
US-20090220444-A1 Antiperspirant and Deodorant Compositions with Improved Protective Action HENKEL AG & CO. KGAA (DE) 2009-09-03 US disclosed
WO-2008065072-A1 CLEANSING OR CARE PRODUCT HENKEL AG & CO. KGAA (DE) 2008-06-05 WO disclosed
WO-2008058943-A2 LOW-RESIDUE COSMETIC OR DERMATOLOGICAL STICK BASED ON AN OIL-IN-WATER DISPERSION/EMULSION III HENKEL AG & CO. KGAA (DE) 2008-05-22 WO disclosed
WO-2008025698-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS WITH IMPROVED CARE EFFECT HENKEL AG & CO. KGAA (DE) 2008-03-06 WO disclosed
EP-1813310-A2 Cosmetic stick based on an oil in water dispersion/emulsion Henkel Kommanditgesellschaft auf Aktien (DE) 2007-08-01 EP disclosed
EP-1803660-A1 Emulsion spray Henkel Kommanditgesellschaft auf Aktien (DE) 2007-07-04 EP disclosed
EP-1156775-B1 REDUCTION OF HAIR GROWTH GILLETTE CO (US) 2006-05-17 EP disclosed
EP-1156775-A1 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 2001-11-28 EP disclosed
US-6121269-A TOPICALLY APPLYING A PROTEIN-TYROSINE KINASE INHIBITOR TO SKIN TO REDUCE ANDROGEN-STIMULATED HAIR GROWTH WITHOUT SIDE EFFECTS GILLETTE COMPANY, THE, A DELAWARE CORPORATION 2000-09-19 US disclosed
WO-2000050002-A1 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 2000-08-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100047296-A1 Low-Residue Cosmetic Or Dermatological Stick Based On An Oil-In-Water Dispersion/Emulsion III TYR, POLR1C, CUTA ALDH1A1 1276/4885EGFR 1891/4885MEN1 4698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.